EP1058550A4 - Substituierte semicarbazide und deren verwendung - Google Patents
Substituierte semicarbazide und deren verwendungInfo
- Publication number
- EP1058550A4 EP1058550A4 EP99905734A EP99905734A EP1058550A4 EP 1058550 A4 EP1058550 A4 EP 1058550A4 EP 99905734 A EP99905734 A EP 99905734A EP 99905734 A EP99905734 A EP 99905734A EP 1058550 A4 EP1058550 A4 EP 1058550A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- substituted semicarbazides
- semicarbazides
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7371098P | 1998-02-04 | 1998-02-04 | |
US73710P | 1998-02-04 | ||
PCT/US1999/002419 WO1999039712A1 (en) | 1998-02-04 | 1999-02-04 | Substituted semicarbazides and the use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1058550A1 EP1058550A1 (de) | 2000-12-13 |
EP1058550A4 true EP1058550A4 (de) | 2002-12-18 |
Family
ID=22115328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99905734A Withdrawn EP1058550A4 (de) | 1998-02-04 | 1999-02-04 | Substituierte semicarbazide und deren verwendung |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1058550A4 (de) |
JP (1) | JP2002511387A (de) |
AU (1) | AU754681B2 (de) |
CA (1) | CA2319484A1 (de) |
IL (1) | IL137671A0 (de) |
MX (1) | MXPA00007585A (de) |
WO (1) | WO1999039712A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479484B1 (en) | 1997-11-21 | 2002-11-12 | Euro-Celtique S.A. | Substituted 2-aminoacetamides and the use thereof |
GB9727523D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Alpha-aminoamide derivatives useful as analgesic agents |
EP1115842A4 (de) | 1998-09-25 | 2002-08-21 | Glycox Corp Ltd | Fructosamin-oxidase assay: verfahren und materialien |
CN1324234A (zh) | 1998-09-25 | 2001-11-28 | 格利科克斯有限公司 | 果糖胺氧化酶,拮抗剂和抑制剂 |
US6281211B1 (en) | 1999-02-04 | 2001-08-28 | Euro-Celtique S.A. | Substituted semicarbazides and the use thereof |
DE60022333T2 (de) | 1999-04-09 | 2006-07-06 | Euro-Celtique S.A. | Natrium kanalblocker zusammensetzungen und deren verwendung |
GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
ATE317280T1 (de) | 2001-09-03 | 2006-02-15 | Newron Pharm Spa | Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung |
ES2386782T3 (es) | 2002-03-08 | 2012-08-30 | Philera New Zealand Limited | Prevención y/o tratamiento de la enfermedad cardiovascular y/o la insuficiencia cardíaca asociada |
MXPA05002883A (es) | 2002-08-20 | 2005-10-05 | Protemix Corp Ltd | Formas de dosis y terapias relacionadas. |
EP1438956A1 (de) | 2003-01-16 | 2004-07-21 | Newron Pharmaceuticals S.p.A. | Alpha-Aminoamidderivate die als Antimigränemittel nützlich sind |
WO2006027705A2 (en) | 2004-07-19 | 2006-03-16 | Protemix Corporation Limited | Synthesis of triethylenetetramines |
JP2014500303A (ja) | 2010-12-22 | 2014-01-09 | パーデュー、ファーマ、リミテッド、パートナーシップ | ナトリウムチャネル遮断剤としての置換ピリジン |
WO2013064883A1 (en) | 2011-10-31 | 2013-05-10 | Purdue Pharma L.P. | Heteroaryl compounds as sodium channel blockers |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1208769A (en) * | 1966-11-24 | 1970-10-14 | Esteve Labor Dr | New bisazomethines and medicines containing them |
US4694004A (en) * | 1984-07-09 | 1987-09-15 | Fujisawa Pharmaceutical Co., Ltd. | Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
US4866173A (en) * | 1982-09-22 | 1989-09-12 | Rorer Pharmaceutical Corporation | Therapeutic substituted semicarbazides |
WO1996040628A1 (en) * | 1995-06-07 | 1996-12-19 | The University Of Saskatchewan | Semicarbazones having cns activity and pharmaceutical preparations containing same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH480308A (de) * | 1966-08-11 | 1969-10-31 | Ciba Geigy | Verfahren zur Herstellung von Thiosemicarbazid-Verbindungen |
EP0144853B1 (de) * | 1983-11-21 | 1990-09-26 | Fujisawa Pharmaceutical Co., Ltd. | Semicarbazid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
-
1999
- 1999-02-04 IL IL13767199A patent/IL137671A0/xx unknown
- 1999-02-04 WO PCT/US1999/002419 patent/WO1999039712A1/en not_active Application Discontinuation
- 1999-02-04 CA CA002319484A patent/CA2319484A1/en not_active Abandoned
- 1999-02-04 AU AU25831/99A patent/AU754681B2/en not_active Ceased
- 1999-02-04 EP EP99905734A patent/EP1058550A4/de not_active Withdrawn
- 1999-02-04 JP JP2000530210A patent/JP2002511387A/ja not_active Withdrawn
- 1999-02-04 MX MXPA00007585A patent/MXPA00007585A/es unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1208769A (en) * | 1966-11-24 | 1970-10-14 | Esteve Labor Dr | New bisazomethines and medicines containing them |
US4866173A (en) * | 1982-09-22 | 1989-09-12 | Rorer Pharmaceutical Corporation | Therapeutic substituted semicarbazides |
US4694004A (en) * | 1984-07-09 | 1987-09-15 | Fujisawa Pharmaceutical Co., Ltd. | Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
WO1996040628A1 (en) * | 1995-06-07 | 1996-12-19 | The University Of Saskatchewan | Semicarbazones having cns activity and pharmaceutical preparations containing same |
Non-Patent Citations (2)
Title |
---|
PUTHUCODE R N ET AL: "Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, EDITIONS SCIENTIFIQUE ELSEVIER, PARIS, FR, vol. 33, no. 7-8, 8 July 1998 (1998-07-08), pages 595 - 607, XP004140553, ISSN: 0223-5234 * |
See also references of WO9939712A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999039712A9 (en) | 1999-10-21 |
WO1999039712A1 (en) | 1999-08-12 |
AU2583199A (en) | 1999-08-23 |
MXPA00007585A (es) | 2002-10-17 |
IL137671A0 (en) | 2001-10-31 |
EP1058550A1 (de) | 2000-12-13 |
CA2319484A1 (en) | 1999-08-12 |
JP2002511387A (ja) | 2002-04-16 |
AU754681B2 (en) | 2002-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1032377A4 (de) | Substituierte 2-aminoacetamide und anwendung davon | |
AP2001002286A0 (en) | Compound and its use | |
HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
HU9903361D0 (en) | Filter-device with collecting-vessel and with heating-device | |
IL148545A0 (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof | |
HUP0003332A3 (en) | Triazole compounds and the use thereof as dopamine-d3-ligands | |
PL343923A1 (en) | New use | |
EP1102535A4 (de) | Verbindungen und verfahren | |
GB9813271D0 (en) | Composition and use | |
GB9818914D0 (en) | Use | |
HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
GB9814640D0 (en) | New use | |
EP1056455A4 (de) | Epimorhin-verbindung und dessen verwendung | |
EP1058550A4 (de) | Substituierte semicarbazide und deren verwendung | |
HUP0103473A3 (en) | Phosphoglycolipid and methods for its use | |
GB9702354D0 (en) | Compounds and their use | |
PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
GB9811168D0 (en) | Direct hair-colouring compositions and the use thereof | |
ZA200006206B (en) | Benzazole compounds and their use. | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
IL145711A0 (en) | Thrombospondin-2 and uses thereof | |
GB9904924D0 (en) | Fungicide use | |
HUP0002343A3 (en) | Fungicidal mixtures and use thereof | |
GB9807503D0 (en) | Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000904 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE CH DE ES FR GB IE IT LI NL |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20021107 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): BE CH DE ES FR GB IE IT LI NL |
|
17Q | First examination report despatched |
Effective date: 20030228 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060117 |